InvestorsHub Logo
Followers 94
Posts 11197
Boards Moderated 0
Alias Born 11/02/2003

Re: None

Tuesday, 01/29/2019 9:17:42 AM

Tuesday, January 29, 2019 9:17:42 AM

Post# of 2794
NEWS -- Actinium Pharmaceuticals to Host Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T on February 7th

PR Newswire•January 29, 2019
  • Event to feature Dr. Sergio Giralt, Chief of Adult Bone Marrow Transplant at Memorial Sloan Kettering Cancer Center
  • Event will also highlight Actinium's recent advances including combination trials with venetoclax, bio-betters and other initiatives enabled by its AWE or Antibody Warhead Enabling technology platform
http://www.prnewswire.com/news-releases/actinium-pharmaceuticals-to-host-key-opinion-leader-breakfast-on-targeted-conditioning-for-bone-marrow-transplant-and-car-t-on-february-7th-300785622.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News